Den Europæiske Union - dansk - EMA (European Medicines Agency)

stemline therapeutics b.v. - elacestrant - bryst neoplasmer - endokrine terapi - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - antineoplastiske midler - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies.  follicular lymphoma (fl) that is refractory to at least two prior  systemic therapies.

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

orion corporation - trimethoprim - filmovertrukne tabletter - 100 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

orion corporation - trimethoprim - oral suspension - 10 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

ethypharm - glycopyrroniumbromid - injektionsvæske, opløsning - 200 mikrogram/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

actavis group ptc ehf. - topiramat - filmovertrukne tabletter - 100 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

actavis group ptc ehf. - topiramat - filmovertrukne tabletter - 200 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

actavis group ptc ehf. - topiramat - filmovertrukne tabletter - 25 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

actavis group ptc ehf. - topiramat - filmovertrukne tabletter - 50 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

orion corporation - carbidopamonohydrat, levodopa - tabletter - 12,5+50 mg